Why the study?
Does combining Qian Yang He Ji (QYHJ) with an ARB improve arterial functionality and blood pressure in hypertensive patients?
Does combining Qian Yang He Ji (QYHJ) with an ARB improve arterial functionality and blood pressure in hypertensive patients?
The addition of the traditional Chinese medicine QYHJ to ARB therapy may further improve arterial stiffness and blood pressure in hypertensive patients.
Answers are grounded in this paper and cite their sources.
May support adding QYHJ to ARB for better arterial stiffness and BP control in hypertension; extends RCT evidence on TCM adjuncts.
Qian Yang He Ji (QYHJ) is a traditional Chinese medicine composed of Digitalis purpurea, Uncaria gambir, Fructus tribuli terrestris, and Ligustrum lucidum. Here, we explored whether combining an antihypertensive angiotensin II receptor blocker (ARB) therapy with QYHJ can improve the arterial functionality of hypertensive patients. One hundred and eight hypertensive patients were randomized into 2 groups; 1 group (n = 53) was treated with ARB and the other group (n = 55) was treated with ARB combined with QYHJ. Each of the 2 groups included 3 subgroups (pure hypertension, hypertension with diabetes, and hypertension with coronary heart disease) and was further divided into patients with and without complications. The cardioankle vascular index and intima-media thickness and pulse pressure were the outcome evaluation parameter. Combined QYHJ and ARB treatment reduced the values of cardioankle vascular index, systolic blood pressure, diastolic blood pressure, and pulse pressure to significantly lower levels than ARB treatment alone did in hypertension patients after 6 months of treatment. ARB improves hypertension, but a combined QYHJ treatment can additionally ameliorate the arterial functionality not only in solely hypertensive patients but also in hypertensive patients with diabetes and coronary heart disease complications. QYHJ coapplication might be a choice to further improve the arterial functionality during an ARB hypertension treatment.
No takes yet. Share an insight, caveat, or question.
Xu et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: